Exchange of expertise
A specialist in particle therapy treatment planning from the Mayo Clinic in the US, Professor Chris Beltran, recently visited ANSTO for an exchange for information.
Showing 1441 - 1460 of 3461 results
A specialist in particle therapy treatment planning from the Mayo Clinic in the US, Professor Chris Beltran, recently visited ANSTO for an exchange for information.
Spatz neutron reflectometer becomes 15th neutron scattering instrument that is used for studies of biological materials and other soft matter.
This afternoon, the Chair of ANSTO, Dr Annabelle Bennett, wrote to all staff to let them know that CEO Dr Adi Paterson has decided to resign. She said the Board is deeply appreciative of the contributions Adi has made, including to the health, research and academic outputs of ANSTO during his tenure. Mr Shaun Jenkinson will continue as Acting CEO, while the Board undertakes a global search for a permanent CEO.
Use of nuclear techniques to benefit industry and consumers
The independent nuclear regulator, ARPANSA, is currently accepting submissions about ANSTO’s planned $59.8 million Intermediate Level Solid Waste Storage Facility.
Frequently asked questions about beamtime, accommodation and the user portal.
First Asia Oceania Forum held at the Australian Synchrotron
ANSTO has made two public submissions to parliamentary inquiries with another to be submitted in February 2020 on matters relating to nuclear technologies, their peaceful applications, and the nuclear fuel cycle.
A major study has identified urbanisation and climate change as future threats to drinking water quality.
ANSTO’s Siobhan Tobin has been awarded the 2019 Rhodes Scholarship for Victoria which is one of the most prestigious scholarship programmes internationally.
Consortium will map the 86 billion nerve cells, 100 trillion connections and neurotransmitters in the human brain.
New researcher joins human health team to focus on role of acquired immunity in preventing disease
In space, without the protection of the magnetosphere, the type and dose of radiation is considerably different to what is naturally experienced on earth. However, it is the secondary particles of lower energies created when galactic and cosmic radiation interacts with shielding that is of concern for astronauts.
In collaboration with the French National Institute of Health and Medical Research (INSERM) and the French International Space Agency (CNES), ANSTO scientists are undertaking research on the radiobiological effects of secondary particles that are created when radiation interacts with the shielding on the International Space Station.
Today The Australian ran a story entitled “Fears for indigenous lands as foreign nuclear waste headed our way”, 18 September 2018. ANSTO was not contacted in relation to the article, but can provide the following information in response which can be attributed to a spokesperson.
Year 11 STEM student and aspiring physicist was given the opportunity of a lifetime to tour ANSTO’s Lucas Heights campus and meet some of Australia’s top researchers.